文献速递关节外科

大型肿瘤假体用于治疗髋膝关节假体周围感染的临床结局

Clinical Outcome of Massive Endoprostheses Used for Managing Periprosthetic Joint Infections of the Hip and Knee.
PubMed 文献 · J Arthroplasty · 2017-10-05

该回顾性研究纳入2007至2014年间因复杂关节置换或内固定后慢性感染行髋、膝大型肿瘤假体置换的69例患者,评估感染根除率、并发症、假体生存率、死亡率和功能结局。结果显示假体周围感染根除率为72%,髋关节(83%)高于膝关节(59%)(P = .038),5年假体生存率为81%(95%CI 74-88),作者认为该研究支持在复杂多次翻修病例中使用肿瘤假体根除假体周围感染。

要点

  • 假体周围感染总根除率为72%,髋关节83%高于膝关节59%(P = .038)。
  • 5年假体生存率为81%(95%CI 74-88)。
  • 平均牛津髋评分22分(范围4-39),平均牛津膝评分21分(范围6-43)。

核心结论

  • 该研究支持在复杂、多次翻修的病例中使用肿瘤假体根除假体周围感染,感染根除率为72%且功能结局可接受。

研究设计与样本

  • 回顾性 review 了2007年至2014年间因复杂关节置换或骨折固定后慢性感染而行的所有髋、膝肿瘤假体置换。
  • 共纳入69例肿瘤假体置换(29膝、40髋),平均年龄68岁(范围43-92)。

主要发现

  • 感染复发19例(28%):5例行冲洗清创,5例行翻修,1例行膝上截肢,8例继续长期抗生素治疗。
  • 假体周围感染根除50例(72%),髋关节根除率83%高于膝关节59%(P = .038)。
  • 5年假体生存率为81%(95%CI 74-88)。
  • 平均牛津髋评分为22分(范围4-39),平均牛津膝评分为21分(范围6-43)。
  • 微生物培养:混合菌生长占36%,凝固酶阴性葡萄球菌占28%,金黄色葡萄球菌占10%。

关键数值与推荐

  • 原文未报告

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endoprosthetic replacement (EPR) is an option for management of massive bone loss resulting from infection around failed lower limb implants. The aim of this study is to determine the mid-term outcome of EPRs performed in the treatment of periprosthetic joint infection (PJI) and infected failed osteosyntheses around the hip and knee joint and identify factors that influence it. METHODS: We retrospectively reviewed all hip and knee EPRs performed between 2007 and 2014 for the management of chronic infection following complex arthroplasty or fracture fixation. Data recorded included indication for EPR, number of previous surgeries, comorbidities, and organism identified. Outcome measures included PJI eradication rate, complications, implant survival, mortality, and functional outcome (Oxford Hip or Knee Score). RESULTS: Sixty-nine EPRs (29 knees and 40 hips) were performed with a mean age of 68 years (43-92). Polymicrobial growth was detected in 36% of cases, followed by coagulase-negative staphylococci (28%) and Staphylococcus aureus (10%). Recurrence of infection occurred in 19 patients (28%): 5 were treated with irrigation and debridement, 5 with revision, 1 with above-knee amputation, and 8 remain on long-term antibiotics. PJI eradication was achieved in 50 patients (72%); the chance of PJI eradication was greater in hips (83%) than in knees (59%) (P = .038). The 5-year implant survivorship was 81% (95% confidence interval 74-88). The mean Oxford Hip Score and Oxford Knee Score were 22 (4-39) and 21 (6-43), respectively. CONCLUSION: This study supports the use of EPRs for eradication of PJI in complex, multiply revised cases. We describe PJI eradication rate of 72% with acceptable functional outcome.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Alvand A, Grammatopoulos G, de Vos F, et al. Clinical Outcome of Massive Endoprostheses Used for Managing Periprosthetic Joint Infections of the Hip and Knee. J Arthroplasty. 2017. PMID: 29107499. doi:10.1016/j.arth.2017.09.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。